| 发明名称 |
METHODS OF REDUCING DOSES OF ERYTHROPOIETIN STIMULATING AGENTS IN HYPORESPONSIVE PATIENTS |
| 摘要 |
The invention provides for methods of treating a dialysis patient that is hyporesponsive to erythropoietin stimulating agents (ESA) comprising administering soluble ferric triphosphate (SFP) composition and administering a dose of ESA that is significantly reduced compared to the dose of ESA required by a dialysis patient that is hyporesponsive to ESA that has not received SFP. |
| 申请公布号 |
US2016250254(A1) |
申请公布日期 |
2016.09.01 |
| 申请号 |
US201415033846 |
申请日期 |
2014.11.04 |
| 申请人 |
ROCKWELL MEDICAL, INC. |
发明人 |
Gupta Ajay;Pratt Raumond;Lin Vivian H.;Guss Carrue |
| 分类号 |
A61K33/26;A61M1/28;A61K45/06;A61K38/18;A61K33/42;A61K9/00 |
主分类号 |
A61K33/26 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating a dialysis patient that is hyporesponsive to erythropoietin stimulating agent (ESA) comprising:
(a) administering to the patient soluble a ferric pyrophosphate composition (SFP), and (b) administering to the patient a dose of ESA that is at least 50% less than the dose of ESA required by dialysis patients that are hyporesponsive to ESA and that have not received SFP. |
| 地址 |
Wixom MI US |
